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Lipid composition was studied in fresh isolated islets 
from normal male rats. Extractable lipids represent 1856 
~g per mg islet protein. In such extracts, phospholipids 
and neutral lipids represent 13.5% and 86.5%, respec- 
tively. Phosphatidylcholine (45.8%) and phosphatidyl- 
ethanolamine {20.6%) were the major components of the 
phospholipid fraction, and phosphatidylinositol (8.9%) 
was the minor component. Esterified cholesterol {38.5%), 
cholesterol (25.5%) and free fatty acids {24.4%) were the 
major components of the neutral lipid fraction. Fatty 
acids esterified to phospholipids account for 619.7 pmol/ 
islet, and 2710 pmoi/islet were esterified to neutral lipids. 
In the phospholipid fraction, saturated and unsaturated 
fatty acids were in a similar proportion. Conversely, in 
the neutral iipids, two-thirds of the fatty acids were un- 
saturated. The o~6 family was the main component of the 
phospholipid unsaturated fatty acids. In the w6 and r 
families, the long-chain fatty acids represent the main 
components. In the neutral lipid fraction, a different 
percentage of each family was found: o~3 > w6 > ~9. The 
long~ain  polyunsaturated fatty acids were also predomi- 
nant species in the (o6 and (o3 families. Further studies 
on the lipid composition of islets, obtained from rats with 
normal and altered islet functions, could provide new in- 
sights into the knowledge of the mechanism of insulin 
secretion. 
Lipids 23, 1125-1128 (1988). 
The ultrastructural and biochemical changes that occur 
in the pancreatic /~-cell plasma membrane during 
emiocytosis, suggest that this organelle plays an active 
role in the last step of insulin secretion (1-3). However, 
several experimental evidences demonstrate that the cell 
membrane also participates in the earlier steps of this 
process, as a source of intracellular signals for the 
stimulus-secretion coupling (4). These signals would be 
released after the activation of several islet phospho- 
lipases (5). In this regard, the early release of arachidonic 
acid and its eicosanoid derivatives (6,8), diacylglycerol (9), 
inositol-l,4,5-triphosphate (IP 3) (10) and other phospho- 
inositides components (11), as well as phosphatidic acid 
(12), were reported by several authors. Moreover, the in- 
crement in the total islet-phospholipid turnover in re- 
sponse to several insulin secretagogne agents has also 
been demonstrated (4,13). All these data suggest that islet 
lipids, and particularly their phospholipid fractions, play 
an important role in the regulation of insulin secretion. 
Despite the large number of reports on this matter, little 
attention has been paid to the normal composition of islet 
lipids. This work was performed to provide such infor- 
mation through the quantitative determination of the 
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Abbreviations: [F)FA, {free) fatty acid; IP 3, inositol-l,4,5-triphos- 
phate; NL, neutral lipid; PC, phosphatidylcholine; PE. phosphatidyl- 
ethanolamine; PI, phosphatidylinositol; PL, phospholipid; PS, 
phosphatidylserine; SPH, sphingomyelin; DB I, double bond index; 
(HP)TLC, (high performance) thin layer chromatography; R, 
DBI/saturated FA ratio. 
different lipid fractions of fresh isolated islets from nor- 
mal male rats. 
MATERIAL AND METHODS 
Adult normal male Wistar rats of ca. 200 g were fed ad 
libitum Purina Rat Chow (CABECA R N'3, Buenos Aires, 
Brazil). This chow contained 33% protein and 10% fat, 
and the following fatty acid composition: 16:0 (21.4%}, 
16:1 (2.1%), 18:0 (8.2%}, 18:1 (24.9%), 18:2co6 (37.7%) and 
20:4(o6 (0.2%). The animals had free access to drinking 
water. In the morning of the experiment, nonfasted rats 
were killed by cervical dislocation without anaesthesia 
and the tail of the pancreas was carefully dissected. Pan- 
creatic islets were isolated from the pancreas by col- 
lagenase (Serva Feinbiochemica, Heidelberg, Germany) 
digestion (14). After such digestion, separation of the 
islets from the acinar tissue was achieved by several 
washings with cold buffer, sedimentation and hand- 
picking under a stereomicroscope. Total lipids were ex- 
tracted from groups of 150 islets with 19 ml of a mixture 
of chloroform]methanol (2:1, v/v) (15) and the washed 
lower phase was used for the analysis of the different lipid 
fractions. All solvents were of chromatographic grade. 
The total lipid content was determined by weighing the 
dry lipid extract resuspended in a small volume of 
chloroform. Neutral lipids (NL) were separated from 
phospholipids (PL) by thin layer chromatography (TLC) 
on plates of Silica Gel G-60, developed with chloroform/ 
methanol/acetic acid/water (90:6:1.0:0.75, v/v/v/v) (16). 
The spots were identified by iodine staining, scraped and 
the NL were eluted with chloroform/methanol (2:1, v/v), 
and the Arvidson's method, chloroform/methanol]acetic 
acid]water (50:39:1:20, v/v/v/v) (17) was used for the elu- 
tion of the PL. The extracts were evaporated to dryness 
under a stream of N2. Recovery control was performed 
at every step using an islet-lipid extract labeled with 
[14C]palmitic acid and appropriate standards labeled 
with [3H]glycerol. Final values were adjusted to the cor- 
responding percentage recovery. A double control was 
used to assess the percentage composition of islet PL and 
neutral lipids, i.e., a scanner measurement performed 
directly on the thin layer plates and the determination 
of radioactivity in the samples eluted from those plates. 
Identical percentage values were obtained using either 
method. 
Different fractions of NL or PL were separated on 
HPTLC plates (Silica Gel 60 F254 precoated for HPTLC, 
E. Merck, Darmstadt, Federal Republic of Germany). A 
developing solvent mixture consisting of petroleum ether/ 
diethyl ether/acetic acid (80:20:1, v/v/v) (18) was used to 
identify the different NL fractions. A solvent mixture of 
chloroform/methanol]30% aq. ammonia]water (140:50:7:3, 
v/v/v/v) and of chloroform/methanol/acetic acid]water 
(160:20:4:1.5, v/v/v/v) (19) was used to separate the 
PL fraction into its different constituents. Appropriate 
standards (P-L Biochemicals, Inc., Milwaukee, WI) were 
simultaneously run to identify each PL component. After 
chromatography, the lipids were charred for densitometry. 
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Plates were dipped into a 3%-cupric-acetate (wlv)-8%- 
phosphoric-acid {v/v) solution and heated at 180~ for 
15 rain {20). The plates were later scanned using a 
Shimadzu scanning densitometer in the reflectance mode. 
Fatty acid (FA) methyl esters from PL or NL were ob- 
tained by refluxing the extracts for 3 hr at 65~ with 
HCl/methanol as described by St6ffel et al. {21). The 
methyl esters were then separated in a gas liquid chro- 
matograph (GC-RIA Shimadzu) with a Supelco column 
(1-1851), 10% SP 2330 on 100/120 chromosorb AW Zog) 
and dual flame ionization detectors using a programmed 
temperature procedure. 
The peaks obtained in the chromatograms were iden- 
tified running appropriate standards of the purest avail- 
able grade iP-L Biochemicals, Inc., Milwaukee, WI) and 
quantitatively estimated using the All-20:1 FA {P-L 
Biochemicals, Inc., Milwaukee, WI) as internal standard. 
Protein concentration was determined according to 
L o w r y ' s  m e t h o d  (22), u s i n g  bovine  s e r u m  a lbumin  (S igma 
Chemica l  Co., St .  Louis ,  MO) as  s t a n d a r d .  
S t a t i s t i c a l  ana lys i s  of the  d a t a  was  pe r fo rmed  us ing  the  
S t u d e n t ' s  t - t e s t  for i n d e p e n d e n t  s amples .  
RESULTS 
F r e s h  i so l a t ed  r a t  i s le t s  compr i s ed  1856 ~g per  m g  of pro- 
t e in  of  t o t a l  e x t r a c t a b l e  l ip ids .  E i t h e r  t he  s u m  of  t he  dif- 
fe rent  is le t - l ip id  f rac t ions  or  the  d i rec t  we igh t  of the  t o t a l  
i s le t - l ip id  e x t r a c t  gave  s imi la r  f igures  for t h i s  p a r a m e t e r .  
F r o m  th i s  to ta l ,  t he  P L  f rac t ion  r e p r e s e n t e d  13.50%, and  
t h e  r e m a i n i n g  86.5% c o r r e s p o n d e d  to  NL.  T a b l e  1 shows  
the  d i f fe ren t  spec ies  iden t i f i ed  in t he  P L  i s l e t  f rac t ion .  
The  l a r g e s t  p e r c e n t a g e  c o r r e s p o n d e d  to  p h o s p h a t i d y l -  
chol ine  {PC) {45.8%), fo l lowed b y  p h o s p h a t i d y l e t h a n o l -  
amine  (PE) {20.6%}, p h o s p h a t i d y l s e r i n e  (PS) (14%), sphin- 
g o m y e l i n  {SPH) {10.7%) a n d  p h o s p h a t i d y l i n o s i t o l  {PI) 
(8.9%). 
The  d i f f e ren t  spec ies  iden t i f i ed  in t he  i s l e t -NL f r ac t i on  
a re  l i s t ed  in Tab le  2. The  m a j o r  c o m p o n e n t  was  t he  
es te r i f i ed  cho les te ro l  (38.5%) fol lowed b y  cho les te ro l  and  
free f a t t y  ac ids  ( F F A )  {25.5% and  24.4%, respec t ive ly ) ,  
a n d  t h e  t r i a c y l g l y c e r o l  f rac t ion ,  t h e  m i n o r  c o m p o n e n t .  
The  d i f ferent  F A  ident i f ied  in t he  i s l e t -PL N L  f rac t ions  
are  p r e s e n t e d  in T a b l e  3. The  a m o u n t  of F A  e s t e r i f i ed  to  
P L  was  619 _+ 50.8 pmol ] i s l e t  in = 6), a n d  2710 +_ 188 
pmol ] i s l e t  in = 6) c o r r e s p o n d s  to  t h e  N L  f rac t ion .  
TABLE 1 
Phospholipid Composition of Fresh Isolated Islets 
Phospholipids ng/Islet ~glmg Protein % 
Phosphatidylserine 22.9 +. 1.4 35.2 14.0 
Phosphatidylinositol 14.4 +. 1.4 22.2 8.9 
Sphingomyelin 17.5 ___ 1.9 26.9 10.7 
Phosphatidylcholine 74.6 +- 5.2 114.8 45.8 
Phosphatidylethanolamine 33.5 ___ 4.1 51.5 20.6 
Total 162.9 +. 11.10 250.6 
Phospholipid fractions were separated by HPTLC and the different 
species identified and quantitatively measured, as described in 
Material and Methods. Each value represents the mean +_ SEM of 
four different islet homogenates. 
A s imi la r  p e r c e n t a g e  of s a t u r a t e d  a n d  u n s a t u r a t e d  F A  
was  found  in t he  phospho l ip id  f ract ion.  Converse ly ,  in t he  
N L  f rac t ion ,  t w o - t h i r d s  of  t he  F A  were  u n s a t u r a t e d .  
A c c o r d i n g l y ,  t he  doub le  b o n d  index  (DBI)  and  the  D B I /  
s a t u r a t e d  F A  r a t i o  (R) were  l a rge r  in t h e  N L  t h a n  in t he  
P L  f rac t ion .  
The  co6 f a m i l y  r e p r e s e n t s  t he  m a i n  c o m p o n e n t  of  t he  
P L - u n s a t u r a t e d  F A .  In  t h i s  f ami ly ,  t he  l a r g e s t  compo-  
n e n t s  were  t h o s e  w i t h  20 and  22 ca rbons .  A s imi l a r  com- 
p o s i t i o n  has  been  d e s c r i b e d  in t he  o u t e r  a c r o s o m a l  mem-  
b r a n e s  of  m a m m a l i a n  s p e r m  (23). The  long-cha in  po lyun-  
s a t u r a t e d  f a t t y  ac ids  also r e p r e s e n t  the  ma in  c o m p o n e n t s  
of  t he  co3 fami ly .  A d i f f e ren t  p e r c e n t a g e  of  each  f ami ly  
was  found  in t he  N L  f rac t ion ,  n a m e l y  oo3 > co6 > co9. A s  
TABLE 2 
Neutral Lipid Composition of Fresh Isolated Islets 
Lipid ng/Islet ~g/mg Protein % 
Cholesterol 266 +. 22 409 25.5 
Free fatty acids 254 -4-_ 10 391 24.4 
Triacylglycerol 122 +. 12 188 11.7 
Esterified cholesterol 401 +. 13 618 38.5 
Total 1043 +_ 29 1606 
Lipids were fractioned and quantitatively measured as described in 
the text. Each value represents the mean +. SEM of four different 
islet homogenates. 
TABLE 3 
Fresh Islet Fatty Acids Composition 
Fatty acid Phospholipis Neutral lipids 
12:0 0.8 --+ 0.2 0.8 +. 0.1 
14:0 3.3 +. 0.5 3.3 +. 0.2 
15:0 1.5 +. 0.3 2.7 +- 0.4 
16:0 22.5 +_ 2.6 14.4 +. 1.0 
16:1 6.1 - 0.9 5.0 +. 0.5 
18:0 15.1 _ 1.7 7.1 +_ 0.7 
18:1co9 13.3 --4-_ 1.3 7.2 +_ 0.4 
20:1co9 0.2 +. 0.0 1.5 +. 0.3 
20:3c~9 0.3 +. 0.1 0.6 +. 0.2 
18:2~06 4.2 +_ 0.4 1.9 +. 0.1 
18:3~06 0.7 _+ 0.3 1.0 +. 0.1 
20:2r 0.1 +. 0.0 1.0 +. 0.2 
20:3r 0.7 +- 0.3 1.8 +. 0.1 
20:4~6 4.6 +. 0.6 3.9 +. 0.3 
22:2co6 5.6 +. 1.1 4.0 +. 0.9 
22:4co6 4.5 +. 0.7 5.4 _ 0.5 
22:3r 3.2 _ 0.7 4.3 + 0.6 
18:3a~3 1.3 +. 0.2 2.4 +. 0.3 
20:5co3 0.3 +- 0.2 3.4 _ 0.3 
22:3w3 4.8 +. 0.9 7.9 +. 0.9 
22:4co3 3.2 _ 0.7 5.0 +. 0.6 
22:5co3 2.9 _ 1.1 7.0 --4"_ 1.2 
22:6co3 0.7 +. 0.5 8.4 +- 1.2 
Sat FA 43.3 28.5 
DBI 141.7 240.8 
R 3.3 8.5 
The lipids were interesterified and the resulting fatty acid methyl 
esters were analyzed as described in the text. Each value represents 
the mean percentage _+ SEM of four determinations; DBI = dou- 
ble bond index; R = DBI/saturated FA ratio. 
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in the PL fraction, long-chain polyunsaturated FA were 
the predominant species found in the w6 and r families. 
DISCUSSION 
It is well known that the lipid composition of animal 
tissues, even among a given species, varies from one 
tissue to another, being affected by several factors such 
as diet composition, sex, age, circadian rhythms and en- 
vironmental conditions {24}. In our experimental model, 
the effect of the enzymes from the exocrine pancreas 
released during the isolation of islets, could also repre- 
sent another source of variation. In islets isolated from 
normal nonfasted male Wistar rats, such composition 
shows an uneven proportion of polar (13.5 % ) and neutral 
lipids (86.5%}. 
The total content of PL currently described, expressed 
on a per-islet basis, agrees with the values reported by 
Hallberg (25) in Wistar rats. Conversely, they are signifi- 
cantly lower than the values reported by Montague and 
Parkin (26} in guinea pig islets. According to Hallberg 
(25}, this difference probably reflects species variations 
of the total PL content of islets. Hallberg stated also that 
the total content of PL is not affected by different condi- 
tions like 48-hr starvation, the culture of the isolated 
islets for one week, the addition of leucine and gliclazide 
to or the removal of ca  2+ from such medium {25}. We 
have previously shown that  the PL content was signifi- 
cantly lower in islets isolated from hypothyroid rats {27). 
Hence, those results might indicate that chronic rather 
than acute conditions {or effects} can modify the total con- 
tent of islet PL, which could affect the release of insulin. 
PL fractions identified in the islets are similar to those 
described in other rat tissues. PC and PE are their major 
components, as in normal liver {24,28} with PS instead 
of PI being the minor component in the islets. Otherwise, 
the percentages of PC and PE are lower in the islets, but 
PS and SPH are higher than in the liver. The relative con- 
tent of the different PL classes currently described in the 
islets isolated from normal nonfasted Wistar rats, with 
PC and PE as major components, coincides with the data 
reported from obese hyperglycemic {29) or NMRI mice 
{25) and Sprague-Dawley rats {30}. This islet PL composi- 
tion is significantly altered in some pathological condi- 
tions such as hypothyroidism {27), which is accompanied 
by a decrease in the insulin secretory response to glucose. 
These data suggest that the normal islet-PL composition 
might be a condition necessary to achieving an adequate 
fl-ceU secretory response. 
The amount of NL per mg of protein was similar in liver 
and isolated islets t31). However, the esterified choles- 
terol, the cholesterol and the FFA fractions were larger, 
but the triacylgiycerol fraction was lower in the islets 
compared to liver. 
The islets, like other rat tissues, present a complex 
composition of esterified FA, with a clear predominance 
of even-numbered acids (32). Berne has concluded that the 
major source for these FA is their extracellular uptake 
rather than their biosynthesis {33). Palmitic acid was the 
largest component of the saturated FA as in the heart 
{34}. This fact could, at least in part, explain: a) the high 
and concentration-dependent oxidation rate of palmitic 
acid measured in islets {35} and b) the large incorpora- 
tion of labeled palmitate into the islet lipids by islets in- 
cubated in the presence of different insulin secretagogue 
agents {36). 
Turk et al. have already reported on the FA composi- 
tion of the major glycerolipids from SpragueoDawley-rat 
islets cultured overnight and then incubated with glucose 
{30}. No references are given in this paper on the FA com- 
position in freshly untreated islets. As shown in our 
Table 3, they also found that palmitate and stearate were 
the predominant saturated FA esterified to PL. Con- 
versely, some discrepancies were found in the composi- 
tion of unsaturated FA. We have previously reported that 
the percentage composition of polyunsaturated FA 
changed significantly in islets incubated with high glu- 
cose {37}. This effect was attributed to a possible effect 
of glucose on the activity of islet desaturases and the FA 
chain-elongation process {37). Hence, the different meta- 
bolic conditions of the islets used in the current report 
and those mentioned above could, at least in part, explain 
the apparent discrepancies in the percentage distribution 
of polyunsaturated FA. The different number of FA con- 
sidered in Turk's study compared with our own (ll  vs 22), 
could also contribute to such a difference. However, we 
do not have a plausible explanation for the particular 
lower percentage of arachidonic acid found in our 
experiments. 
A large number of a long-chain polyunsaturated FA 
was found in the islets, mainly esterified to the neutral 
lipids. The richness of polyunsaturated FA is a charac- 
teristic of the lipid composition found in very active 
tissues, such as heart and liver {38}. Such composition ex- 
plains the large DBI and R {DBI/saturated acid ratio} 
found in the islets {37). The degree of unsaturation of the 
phospholipid acyl chains has been considered one of the 
main determinants of the microviscosity of lipid regions 
{39}. Assuming that the PL content grossly represents 
the islet membrane composition, the values obtained for 
such a parameter would suggest that, in the islets, the 
microviscosity of the membrane lipids is lower than in 
the liver membranes. 
It has already been reported that the oxidation of 
endogenous FA accounts for about 30% of islet basal 
respiratory rate {40}. The large amount of endogenous 
islet FA, mainly esterified to the neutral lipid fraction, 
could easily provide such an oxidizable substrate. In ad- 
dition, the FA also represent the source of intraceUular 
signals for the stimulus-secretion coupling. The change 
in the mass of FA esterified to PC {30}, the release of 
arachidonic acid {6,7) and its eicosanoid derivatives 
{6-8,36} under the glucose stimulus are clear examples 
of such function. 
Further, more detailed studies on the composition and 
metabolism of islet lipids in normal and pathological con- 
ditions would provide important evidence for a more com- 
prehensive knowledge of the insulin secretion mechanism. 
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